Skip to main content

Table 4 Bivariate and multivariate logistic regression analyses of factors associated with glycemic control among patients with T2DM in TASH, Addis Ababa, Ethiopia, 2021

From: Evaluation of glycemic control and related factors among outpatients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a cross-sectional study

Variable Category Glycemic control (HbA1c) Bivariate Analysis Multivariate Analysis
Good (< 7%) n = 85 Inadequate-poor
(≥ 7%)
n = 240
COR (95% CI) P-value AOR (95% CI) P-value
Age group (yrs.) 18-44 26 48 1 - 1 -
45-54 26 66 0.74 (0.39–1.18) 0.042* 1.63 (0.66–4.18) 0.11
55-64 16 85 1.90 (1.10–3.20) 0.002* 2.46 (1.28–6.01) 0.03*
 ≥ 65 17 41 1.72 (1.02–3.06) 0.008* 1.97 (1.30–5.97) 0.04*
DM duration  ≤ 10 years 72 100 1 - 1 -
 > 10 years 33 120 1.62 (1.13–3.43) 0.001* 3.15 (2.22–6.54) 0.016*
Mode of therapy Oral hypoglycemic agents (OHA) 46 47 1 - 1 -
Insulin 41 104 2.50 (1.30–4.50) 0.001* 3.07 (2.10–6.12) 0.022*
OHA & Insulin 25 50 1.12 (0.24–3.72) 0.029* 2.36 (0.82–5.97 0.073
Diet modification/Exercise alone 11 1 0.52 (0.38–2.88) 0.054 0.91 (0.52–3.53) 0.160
Diet adherence  > 3 days/week 80 88 1 - 1 -
0-3 days/week 45 112 2.32 (1.35–3.99) 0.001* 1.97 (1.28–3.52) 0.002*
Glycemic target goal (HbA1c/FBS/RBS) Yes 82 47 1 - 1 -
No 49 147 2.61 (1.90–4.82) 0.001* 3.42 (2.17–5.97) 0.001*
  1. *Statistically significant
  2. COR Crude Odds Ratio, AOR Adjusted Odds Ratio, CI Confidence Interval